Ariceum stated it is the first company to sponsor a clinical trial using Auger therapy in recurrent glioblastoma treatment.
|
![](https://storage.pardot.com/375012/1629380113Wfu3PKlE/spacer.gif) |
The partnership is said to have improved the productivity and efficiency of the research team.
|
![](https://storage.pardot.com/375012/1629380113Wfu3PKlE/spacer.gif) |
Medidata's Clinical Data Studio will be used to streamline trials and improve patient experience.
|
![](https://storage.pardot.com/375012/1629380113Wfu3PKlE/spacer.gif) |
The company is on schedule to present the topline readout from the THRIVE-2 trial by the end of the year.
|
![](https://storage.pardot.com/375012/1629380113Wfu3PKlE/spacer.gif) |
57.5% of studies focus on the efficacy and safety of potential treatments for NHL in larger patient cohorts.
|
![](https://storage.pardot.com/375012/1629380113Wfu3PKlE/spacer.gif) |
Passage Bio’s gene therapy targets progranulin, which is impactful in frontal temporal dementia, ALS, and Alzheimer’s disease.
|
![](https://storage.pardot.com/375012/1629380113Wfu3PKlE/spacer.gif) |
As the first biologic for COPD could soon be approved by the FDA, other candidates are coming to the end of pivotal studies.
|
![](https://storage.pardot.com/375012/1629380113Wfu3PKlE/spacer.gif) |